The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Veterinary CRO And CDMO Market Through 2030?
The veterinary cro and cdmo market has experienced substantial expansion in recent times. Forecasters predict this market will expand from $7.53 billion in 2025 to $8.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.9%. The significant growth observed historically is primarily due to several factors, including the limited in-house R&D capabilities of veterinary companies, an expanding companion animal population, an increase in the prevalence of animal diseases, the early adoption of CDM/O services within developed regions, and a strong demand for innovative veterinary biologics and drugs.
The veterinary CRO and CDMO market is projected to experience substantial expansion over the coming years, reaching $11.81 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.6%. This anticipated growth during the forecast period is fueled by several factors, including a heightened demand for contract research and manufacturing services, innovations in veterinary drug development technology, the expansion of veterinary biologics and pharmaceuticals, an increase in global regulatory compliance mandates, and the growing use of precision medicine in animal care. Key trends expected during this period involve a rise in outsourcing for veterinary drug development, the broadening of preclinical and clinical trial offerings, an increasing need for regulatory consulting, the implementation of sophisticated analytical and formulation services, and an enhanced emphasis on post-marketing surveillance and pharmacovigilance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp
What Market Drivers Are Helping Shape The Veterinary CRO And CDMO Market Expansion?
Increasing pet ownership is expected to propel the growth of the veterinary CRO and CDMO market going forward. Pet ownership is the state of being the primary person or household responsible for the care, well-being, and control of a domesticated animal. It involves a long-term, legal, and ethical commitment. Increasing pet ownership is rising due to the growing awareness of the emotional and health benefits of having pets, as people seek companionship, stress relief, and improved well-being through pet care. The veterinary CRO and CDMO market supports increasing pet ownership, as the growing number of pets drives demand for the development and manufacturing of veterinary drugs, vaccines, and treatments to ensure pet health and safety. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, ninety-four (94) million U.S. households own at least one pet, compared to eighty-two (82) million in 2023. Therefore, the increasing pet ownership is expected to drive the veterinary CRO and CDMO market going forward.
How Is The Veterinary CRO And CDMO Market Structured Across Different Market Segments?
The veterinary cro and cdmo market covered in this report is segmented –
1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications
Subsegments:
1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization
2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting
3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services
4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance
5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance
What Trends Are Affecting The Veterinary CRO And CDMO Market Dynamics?
Major companies operating in the veterinary CRO and CDMO market are focusing on developing innovative services such as integrated multi-site CDMO networks with advanced sterile manufacturing, lyophilization, and specialized dosage capabilities to streamline drug development lifecycles and accelerate compliant commercialization pathways. Integrated multi-site CDMO networks are unified platforms that combine multiple manufacturing locations and specialized technologies including sterile multidose systems, lyophilization, and flexible packaging under harmonized operational and quality frameworks to deliver end-to-end pharmaceutical development and production services. For instance, in April 2025, Meribel Pharma Solutions, a UK-based full-service CDMO offering drug development, formulation, analytical services, sterile and semi-solid manufacturing, and packaging solutions, launched operations with a network of 13 facilities across France, Spain, and Sweden to support products from early development through commercial-scale production, providing centers of excellence in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health products.
Which Companies Form The Competitive Landscape Of The Veterinary CRO And CDMO Market?
North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access The Complete Veterinary CRO And CDMO Market Report:
https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report
Which Region Leads The Veterinary CRO And CDMO Market By Size?
North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Veterinary CRO And CDMO Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model